about
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaIdentification of a novel IGH-MMSET fusion transcript in a human myeloma cell line with the t(4;14)(p16.3;q32) chromosomal translocationCharacterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretomeTPL2 kinase regulates the inflammatory milieu of the myeloma nicheAltered cytokine and chemokine profiles in multiple myeloma and its precursor diseaseNF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors.Effects of all-trans retinoic acid (ATRA) on human myeloma cells.Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.Immunodeficiency and immunotherapy in multiple myeloma.Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.Plasma cells in immunopathology: concepts and therapeutic strategies.Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma
P2860
Q26784444-B1765106-B963-4E93-8652-F353F5F3083AQ28272420-176F6373-8F8D-4C07-AB0D-C27C443BD6EAQ30496213-E09C87EC-5785-45D6-B78D-EE52047243D1Q33714724-8522CAC2-9095-425B-B37F-82E5E8505ABDQ34103913-C191C428-4F14-485B-8CF1-487E31A4714EQ34285220-CF3E8005-0AAB-4198-A466-C3C8C8A51B0DQ35614620-80B568BA-EF6F-49FF-B810-220062C4BC36Q35653049-55AEBEB3-74CC-4EED-B1CA-7C3E42B084DFQ36904977-EEB86808-6128-4438-8FC3-19E10D21BB55Q37397839-0929E917-1A34-48A4-B286-318A1EAC6187Q38205130-A11E56BD-1BC3-4A4B-880F-CDC940384680Q38708402-AEC6BBF8-B1F2-439F-A588-39C1BCCFB3B2Q40502949-CF67280A-5792-45E3-8C5F-4DF284D5A847Q47158965-8AF81A60-531B-4C11-A055-BDB9EE1F5BBCQ49649026-5B4430CA-A7E2-4D7B-A767-C076961656DB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
IL-10 in myeloma cells.
@ast
IL-10 in myeloma cells.
@en
IL-10 in myeloma cells.
@nl
type
label
IL-10 in myeloma cells.
@ast
IL-10 in myeloma cells.
@en
IL-10 in myeloma cells.
@nl
prefLabel
IL-10 in myeloma cells.
@ast
IL-10 in myeloma cells.
@en
IL-10 in myeloma cells.
@nl
P2093
P1433
P1476
IL-10 in myeloma cells.
@en
P2093
Ayako Ueki
Haruko Sakaguchi
Hideho Wada
Kenichiro Yata
Masako Uno
Takashi Sugihara
Takemi Otsuki
Tomohiro Fujii
P304
P356
10.1080/10428190290021579
P577
2002-05-01T00:00:00Z